Events & Presentations Upcoming Events Jun 14, 2023 6:20 PM EDT Goldman Sachs 44th Annual Global Healthcare Conference Click here for Webcast Add to Outlook Add to Google Calendar Location Dana Point, CA Corporate Presentations May 04, 2023 Kymera Corporate Presentation, May 2023 Dec 14, 2022 Kymera December 14 Investor Webcast Presentation Dec 16, 2021 2021 R&D Day Presentation R&D Day Dec 16, 2021 8:30 AM EST Kymera Therapeutics 2021 R&D Day Click here for Webcast Supporting Materials 2021 R&D Day Presentation 21.8 MB Archived Events Nov 15, 2021 8:40 AM EST Stifel 2021 Virtual Healthcare Conference: Fireside chat Nov 11, 2021 1:00 PM EST Credit Suisse 30th Annual Virtual Healthcare Conference: Fireside chat Oct 27, 2021 10:30 AM EDT Safety, PK and PD from Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers Click here for Webcast Supporting Materials Safety, PK and PD from Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers 4.6 MB Sep 13, 2021 7:00 AM EDT H.C. Wainwright 23rd Annual Global Investment Conference Click here for Webcast Sep 9, 2021 1:15 PM EDT Morgan Stanley 19th Annual Global Healthcare Conference Click here for Webcast Jun 28, 2021 8:00 AM EDT KT-474 Phase 1 Update Call Click here for webcast Supporting Materials KT-474 Phase 1 Update Call Presentation 2.1 MB Jun 20, 2021 11:45 AM EDT 16th ICML Meeting Supporting Materials ICML Meeting Presentation 1.8 MB Jun 9, 2021 4:40 PM EDT Goldman Sachs 42nd Annual Global Healthcare Conference Click here for Webcast May 26, 2021 Ligase Targeting Drug Development Summit Supporting Materials Ligase Targeting Drug Development Summit Presentation 1.8 MB May 25, 2021 12:00 PM EDT UBS Global Healthcare Virtual Conference Click here for Webcast Supporting Materials UBS Global Healthcare Virtual Conference Presentation 4.3 MB Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Next page next › Last page last »
Safety, PK and PD from Single Ascending Dose Portion of KT-474 Phase 1 Trial in Healthy Volunteers 4.6 MB
